Skip to main content
HANDOK Inc. logo

HANDOK Inc. — Investor Relations & Filings

Ticker · 002390 ISIN · KR7002390003 KO Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2022-02-09 AGM Information
Country KR South Korea
Listing KO 002390

About HANDOK Inc.

https://www.handok.co.kr/en/

Handok Inc. is a total healthcare company that develops, manufactures, and distributes a comprehensive range of healthcare solutions. Its portfolio includes prescription drugs, general medicine, medical devices, and in-vitro diagnostics. The company's core business focuses on therapeutic areas such as diabetes, cardiovascular and musculoskeletal diseases, and psychoneurotic disorders, in addition to human vaccines. Positioning itself as a "Health Innovator," Handok provides products and services aimed at prevention, diagnosis, and health management. The company collaborates with global enterprises and manages the entire value chain from sourcing and development to commercialization.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 99% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Handok. It outlines the date, location, and specific agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors, and remuneration limits. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of meeting details and request their participation/votes.
2022-02-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document specifically details changes in share ownership and collateral agreements by major shareholders and their special related parties. It is a mandatory disclosure filing for significant shareholding changes, which falls under the 'Major Shareholding Notification' category.
2022-01-19 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the change in share ownership by the National Pension Service in the company Handok. This type of filing is a mandatory disclosure of significant shareholding changes and falls under the category of Major Shareholding Notification.
2022-01-05 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal 'Report of Stock Option Grant' (주식매수선택권 부여에 관한 신고) filed by Handok Inc. to the Financial Services Commission/Korea Exchange. It details the specific terms of stock options granted to employees, including exercise price, vesting periods, and valuation methodology. This type of filing is a regulatory disclosure regarding capital structure and equity-based compensation, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for general capital changes).
2021-12-17 Korean
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Handok' (주식회사 한독) covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial data, business operations, management discussions, and capital structure information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-11-12 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees, including exercise prices, vesting periods, and valuation methods. This type of disclosure regarding capital structure changes and employee compensation via stock options is classified as a Regulatory Filing (RNS) in the absence of a more specific category like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for general capital changes).
2021-11-01 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.